BlandRC. International health and psychiatry. Can J Psychiatry1996;41:11–5.
2.
National Advisory Mental Health Council. Health care reforms for Americans with severe mental illness. Am J Psychiatry1994;150:1447–65.
3.
LapierreYD. Funding in clinical trials. In: Rae-GrantQ, editor. Images in psychiatry: Canada. Washington (DC): American Psychiatric Press; 1996. p 267–71.
4.
TibboPWarnekeL. Obsessive–compulsive disorder in schizophrenia: Epidemiologic and biologic overlap. J Psychiatry Neurosci1999;24:15–24.
5.
McDougleCJBarrLCGoodmanWKPeltonGHAronsonSC, Anand A, and others. Lack of efficacy of clozapine monotherapy in refractory obsessive-compulsive disorder. Am J Psychiatry1995;152:18120–4.
6.
YoungCRBosticJQMcDonaldCL. Clozapine and refractory obsessive–compulsive disorder: A case report. J Clin Psychopharmacol1994;14:209–11.
7.
PoyurovskyMBergmanYShoshaniDSchneidmanMWeizmanA. Emergence of obsessive-compulsive symptoms and tics during clozapine withdrawal. Clin Neuropharmacol1998;21:97–100.
8.
SteinenTSchmidt MichelPOKaschkaWP. Considerable improvement in a case of obsessive-compulsive disorder in an emotionally unstable personality disorder, borderline type under treatment with clozapine. Pharmacopsychiatry1996;29:111–4.
9.
QuitkinFMStewartJWMcGrathPJNunesEVKleinDF. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry1997;54:970–2.
10.
KendlerKSEavesLJWaltersEENealeMCHeathACKesslerRC. The identification and validation of distinct depressive syndromes in a population-based sample of female twins. Arch Gen Psychiatry1996;53:391–9.
11.
StewartJWTricamoEMcGrathPJQuitkinFM. Prophylactic efficacy of phenelzine and Imipramine in chronic atypical depression: Likelihood of recurrence on discontinuation after 6 months' remission. Am J Psychiatry1997;154:31–6.
12.
PerugiGAkiskalHSLattanziLCecconiDMastrocinqueC, Patronelli A, and others. The high prevalence of “soft” bipolar (II) features in atypical depression. Compr Psychiatry1998;39:63–71.
13.
BenazziF. Prevalence of bipolar II disorder in outpatient depression: A 203-case study in private practice. J Affect Disord1997;43:163–6.
14.
BenazziF. Bipolar II depression in late life: Prevalence and clinical features in 525 depressed outpatients. J Affect Disord. Forthcoming.
15.
BenazziF. Prevalence and clinical features of atypical depression in depressed outpatients: A 467-case study. Psychiatry Res. 1999;86:259–65.
16.
AkiskalHS. The prevalent clinical spectrum of bipolar disorders: Beyond DSM-IV. J Clin Psychopharmacol1996;16(suppl 1):4S–14S.
17.
FirstMBSpitzerRLGibbonMWilliamsJBW. Structured Clinical Interview for DSM-IV Axis I Disorders – Clinician Version (SCID-CV). Washington (DC): American Psychiatric Press; 1997.
18.
MontgomerySAAsbergM. A new depression scale designed to be sensitive to change. Br J Psychiatry1979;134:382–9.
19.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed.Washington (DC): American Psychiatric Association; 1994.
20.
McMahonFJStineCChaseGAMeyersDASimpsonSGDepauloJR. Influence of clinical subtype, sex, and lineality on age at onset of major affective disorder in a family sample. Am J Psychiatry1994;151:210–5.
21.
Lepola UM, and others. A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder. J Clin Psychiatry1998;59:528–34.
22.
Mundo E, and others. Efficacy of fluvoxamine, paroxetine, and citalopram in the treatment of obsessive-compulsive disorders: A single blind study. J Clin Psychopharmacol1997;17:267–71.
23.
Baumann P, and others. A double-blind double-dummy study of citalopram comparing infusion versus oral administration. J Affect Disord1998;49:203–10.
24.
Foglia JP, and others. Plasma levels of citalopram enantiomers and metabolites in elderly patients. Psychopharmacol Bull1997;3:109–12.
25.
Leinonen E, and others. The effect of age and concomitant treatment with other psychoactive drugs on serum concentrations of citalopram measured with a nonenanti-oselective method. Therapeutic Drug Monitoring1996;18:111–7.
26.
Patris M, and others. Citalopram versus fluoxetine: A double-blind, controlled, multicenter, Phase III trial in patients with unipolar major depression treated in general practice. Int Clin Psychopharmacol1996;11:129–36.
27.
SusserEBBrownAMatteTD. Prenatal factors and adult mental and physical health. Can J Psychiatry1999;44:326–34.
28.
ClappJFIIILopezBHarcar-SevcikR. Neonatal behavioral profile of the offspring of women who continued to exercise regularly throughout pregnancy. Am J Obstet Gynecol1999;180:91–4.
29.
FribergASundbergJ. Does music performance allude to locomotion? A model of final ritardandi derived from measurements of stopping runners. J Acoust Soc Am1999;105:1469–84.
30.
FriedmanEH. Neurobiology of the immune system and infection in the effects of psychological factors on the cardiovascular system [letter]. Can J Psychiatry1999;44:284–5.
31.
WangH-CLeesAJBrownP. Impairment of EEG desynchronisation before and during movement and its relation to bradykinesia in Parkinson's disease. J Neurol Neurosurg Psychiatry1999;66:442–6.
32.
MiltnerWHRBraunCArnoldMWitteHTaubE. Coherence of gamma-band EEG activity as a basis for associative learning. Nature1999;397:434–6.
33.
BuchelCCoullJTFristenKJ. The predictive value of changes in effective connectivity for human learning. Science1999;283:1538–41.
SejnowskiTJ. A high point for evolution. Science1999;283:1121.
36.
KochCLaurentG. Complexity and the nervous system. Science1999;284:96–8.
37.
BalanAGandourJ. Effect of sentence length on the production of linguistic stress by left- and right-hemisphere-damaged persons. Brain Lang1999;67:73–94.
38.
ShribergEBatesRStolckeATaylorPJurafskyD, Ries K, and others. Can prosody aid the automatic classification of dialog acts in conversational speech?Lang Speech1998;41:443–92.
39.
KristanWBJr., He's got rhythm: Single neurons signal timing on a scale of seconds (news and views). Nature Neuroscience1999;1:643–5.
40.
RakicP. Young neurons for old brains?Nature Neuroscience1999;1:645.
41.
FriedmanEH. 6-month aerobic exercise training program had no effect on cardiovascular responsivity to a mental arithmetic test in healthy middle-aged adults [letter]. J Psychosom. Res1993;37:553–4.